What is the ICD-10 code for cytosine monophosphate screening?

The ICD-10 code for cytosine monophosphate screening is Z13.29, used for encounters for screening for other metabolic disorders.

When should Z13.29 be used?

Z13.29 should be used for routine newborn screening encounters without a confirmed diagnosis of a metabolic disorder.

ICD-10 Coding for Cytosine Monophosphate Screening(Z13.29, D81.3, E79.8)

Save

Learn about cytosine monophosphate screening, its ICD-10 coding (Z13.29), and essential documentation requirements for accurate medical billing.

Also known as:

CMP ScreeningNucleotide Metabolism Screening

Related ICD-10 Code Ranges

Complete code families applicable to Cytosine Monophosphate Screening

Z00-Z99Primary Range

Factors influencing health status and contact with health services

→

Code Comparison: When to Use Each Code

Compare key differences between these codes to ensure accurate selection

Code	Description	When to Use	Key Documentation
Z13.29	Encounter for screening for other metabolic disorders	Use for encounters where screening is performed without a confirmed diagnosis.	Routine newborn screening panel including tandem mass spectrometry
E79.8	Other disorders of purine and pyrimidine metabolism	Use when specific nucleotide metabolism disorders are confirmed.	CMP-β-D-Neu5Ac elevation > 2 SD above age-adjusted reference range
D81.3	Adenosine deaminase deficiency	Use when adenosine deaminase deficiency is confirmed.	MS/MS showed elevated adenosine/2'-deoxyadenosine ratio ≥ 3.2:1

Primary ICD-10-CM Codes

Encounter for screening for other suspected endocrine disorder

Z13.29Billable

Differential Codes

Alternative codes to consider when ruling out similar conditions

Metabolic disorder, unspecifiedE88.9

Use only if an abnormality is confirmed.

Documentation & Coding Risks

Avoid these common issues when documenting Cytosine Monophosphate Screening.

Vague documentation of screening results

Impact

Clinical: Inadequate information for clinical decision-making., Regulatory: Non-compliance with documentation standards., Financial: Potential denial of claims due to insufficient documentation.

Mitigation

Use specific quantitative results in documentation.

Using Z13.29 for confirmed metabolic disorders

Impact

Reimbursement: Incorrect reimbursement due to misclassification., Compliance: Non-compliance with coding guidelines., Data Quality: Inaccurate data on metabolic disorder prevalence.

Mitigation

Use specific codes like E79.8 or D81.3 for confirmed cases.

Screening Documentation

Impact

Lack of detailed test results in screening documentation.

Mitigation

Implement EHR alerts requiring numeric results for all metabolic screens.

Frequently Asked Questions

Documentation requirements, coding pitfalls and FAQs for conditions coded with Z13.29.

Primary Code

Z13.29

Encounter for screening for other suspected endocrine disorder

Quick Navigation

ICD-10 codes6

Coding risks3

FAQs2

ICD-10 Coding for Cytosine Monophosphate Screening(Z13.29, D81.3, E79.8)

Documentation & Coding Risks

Frequently Asked Questions

What is the ICD-10 code for cytosine monophosphate screening?

When should Z13.29 be used?

Related condition guides